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In the adult animal the sinoatrial node (SAN) rhythmically generates a depolarizing wave
that propagates to the rest of the heart. However, the SAN is more than a simple clock; it
is a clock that adjusts its pace according to the metabolic requirements of the organism.
The Hyperpolarization-activated Cyclic Nucleotide-gated channels (HCN1–4) are the struc-
tural component of the funny (I f) channels; in the SAN the I f current is the main driving
electrical force of the diastolic depolarization and the HCN4 is the most abundant isoform.
The generation of HCN KO and transgenic mouse models has advanced the understanding
of the role of these channels in cardiac excitability. The HCN4 KO models that were first
developed allowed either global or cardiac-specific constitutive ablation of HCN4 channels,
and resulted in embryonic lethality. A further progress was made with the development of
three separate inducible HCN4 KO models; in one model KO was induced globally in the
entire organism, in a second, ablation occurred only in HCN4-expressing cells, and finally
in a third model KO was confined to cardiac cells. Unexpectedly, the three models yielded
different results; similarities and differences among these models will be presented and
discussed. The functional effects of HCN2 and HCN3 knockout models and transgenic
HCN4 mouse models will also be discussed. In conclusion, HCN KO/transgenic models
have allowed to evaluate the functional role of the I f currents in intact animals as well as in
single SAN cells isolated from the same animals.This opportunity is therefore unique since
it allows (1) to verify the contribution of specific HCN isoforms to cardiac activity in intact
animals, and (2) to compare these results to those obtained in single cell experiments.
These combined studies were not possible prior to the development of KO models. Finally,
these models represent critical tools to improve our understanding of the molecular basis
of some inheritable arrhythmic human pathologies.
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INTRODUCTION
In mammals, cardiac pacemaking originates from cells in the
sinoatrial node (SAN) constitutively able to generate rhythmic
action potentials (APs) due to the presence of a spontaneous dias-
tolic depolarization (Boyett et al., 2000; Mangoni and Nargeot,
2008). SAN physiologists have long studied the molecular mecha-
nisms responsible for the diastolic/pacemaker depolarization since
it is this phase that temporally separates and electrically triggers
consecutive APs (DiFrancesco et al., 1986; Biel et al., 2009; Bar-
uscotti et al., 2010a). Several ionic currents and mechanisms that
contribute to SAN cell’s activity are shared with other types of car-
diomyocytes; however, the functional expression of the “funny”
(I f) current in the adult is mostly restricted to the SAN and the
conduction system (Baruscotti et al., 2010a).
Its tissue-specific expression, together with the evidence that
I f is an inward depolarizing current activated within the diastolic
depolarization range of potentials (−40/−60 mV) and modulated
by the second messenger cAMP, clearly indicate that this current
provides a substantial contribution to cardiac pacemaking (Bar-
uscotti et al., 2005; Verkerk et al., 2007a). Since its discovery and
until a decade ago, the vast majority of studies on the I f current
were carried out in single SAN cells isolated from lower mam-
mals, typically rabbit; recent evidence in humans has confirmed
previous conclusions on I f properties and function. More specif-
ically: (1) the presence of I f and HCN1 and HCN4 isoforms has
been verified also in human SAN cells (Verkerk et al., 2007a,b;
Chandler et al., 2009); (2) genetically determined alterations of
the I f channel have been associated with mild or severe forms of
arrhythmias in humans (Baruscotti et al., 2010b); (3) an I f spe-
cific blocker, ivabradine, acts as pure heart rate slowing drug and
is currently used in the therapy of chronic stable angina and heart
failure (DiFrancesco and Camm, 2004).
The molecular determinants of the funny current belong to
the family of Hyperpolarization-activated Cyclic Nucleotide-gated
(HCN) channels which comprises four isoforms (HCN1–4; Bar-
buti et al., 2007; Biel et al., 2009). The subunits can assemble as
homotetramers and/or heterotetramers to form functional chan-
nels. The structural arrangement of each single subunit comprises
six membrane-spanning domains (S1–S6), which include a puta-
tive voltage sensor (S4) and a pore (P) region between the S5 and
S6 segments, and a cyclic-nucleotide-binding domain (CNBD) in
the C-terminus.
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Analysis of HCN distribution in the adult heart indicates that
the HCN4 isoform is the major component of pacemaker chan-
nels in the SAN of all the species analyzed (mouse, rat, rabbit, dog,
human). Species-dependent expression of HCN1 and HCN2 has
also been reported in the SAN, but always at much lower levels
than HCN4; the HCN3 is absent from the SAN; (Ishii et al., 1999;
Shi et al., 1999; Moosmang et al., 2001; Marionneau et al., 2005;
Tellez et al., 2006; Liu et al., 2007; Thollon et al., 2007; Stillitano
et al., 2008; Brioschi et al., 2009; Chandler et al., 2009; Fenske
et al., 2011; Herrmann et al., 2011b). A clear understanding of
the presence of different HCN isoforms in working myocytes is
complicated because of interspecies variability and of contrasting
results between transcriptional and protein data. Despite this, it
is reasonable to say that HCN2 is the predominant isoform both
in atria and ventricles even though at a lower level of expres-
sion compared to the HCN4 level in SAN and the conduction
system. HCN4, HCN3, and HCN1 proteins are only occasion-
ally reported (Shi et al., 1999; Han et al., 2002; Dobrzynski et al.,
2003; Marionneau et al., 2005; Zicha et al., 2005; Yamamoto et al.,
2006; Liu et al., 2007; Stillitano et al., 2008; Chandler et al., 2009;
Fenske et al., 2011; Herrmann et al., 2011b). Taken together, the
observations outlined above and a whole set of experimental find-
ings and numerical reconstruction data (Baruscotti et al., 2005;
DiFrancesco, 2010) indicate clearly the involvement of the I f cur-
rent in cardiac pacemaking. What is the degree of I f involvement in
the complex set of mechanisms that underlie the whole of the cell-
cycling processes active in pacemaker cells is however still a very
much debated issue (Lakatta and DiFrancesco, 2009; DiFrancesco
and Noble, 2012a,b). To determine this, it is also important to
consider that despite the copious amount of studies carried out at
single cell, any conclusion deriving from this work cannot auto-
matically be held valid for the function of the SAN as a whole, in
the absence of experimental confirmation. The availability of the
knockout technology has finally allowed to explore the role of the
I f current within its complex setting of interactions in the living
animal and the pathological states associated with its removal.
HCN4 KO AND TRANSGENIC MOUSE MODELS AND
EMBRYOLOGICAL DEVELOPMENT
HCN KO and transgenic mice have allowed to gain insight on the
role of HCN subunits during embryonic development (Table 1).
Constitutive deletion of the HCN4 gene, either globally or specifi-
cally in the myocardium, causes a premature death of homozygous
embryos between ED9.5 and ED11.5 (Stieber et al., 2003). Analy-
sis of isolated ED9.5 hearts revealed that HCN4 deletion results
in a significant bradycardia (36.7% reduction of heart rate when
compared to wild type animals). The HCN4 knockout resulted
in a 75–90% decrease of the I f current, with the residual cur-
rent being possibly also carried by HCN1 and HCN2 according
to the authors (Stieber et al., 2003). These data confirm that the
HCN4 isoform is the major component of the f-channel also in
the developing SAN. Importantly, studies with specific deletion of
HCN1 and HCN2 indirectly confirmed the role of HCN4 since
in these HCN1 (Nolan et al., 2003) and HCN2 (Ludwig et al.,
2003) knockout animals there was no evidence of cardiac alter-
ations in developing embryos. The fundamental role of HCN4
during cardiac development is supported also by molecular data
on the distribution of HCN4 mRNA in the embryonic heart. In
the mouse, the Hcn4 gene is indeed already expressed in the car-
diac mesoderm at ED7.5; with the progression of development
this expression remains confined to the sinus venosus/SAN and
to the conduction system (Garcia-Frigola et al., 2003; Christoffels
et al., 2010; Vicente-Steijn et al., 2011).
Recently, a similar pattern of HCN4 expression has been found
in the chick embryo (Vicente-Steijn et al., 2011). This early expres-
sion of HCN4 is in agreement with previous evidence that in the
chick embryonic heart, pacemaker activity initiates from the sinus
venosus (the prospective SAN) before the first contraction takes
place (DeHaan, 1965; Van Mierop, 1967). In mice, the first car-
diac contraction is visible around embryonic day 8.5 (ED8.5) at
the tubular heart stage, and at this stage most cardiomyocytes dis-
play rhythmic contractions and express the I f current (Yasui et al.,
2001). After this period, the proportion of cardiac embryonic cells
maintaining a spontaneous activity decreases by about 60–70%, a
decrease that is accompanied by a significant reduction (∼80%)
of the current (Yasui et al., 2001).
Maintenance of a regular, if slower, rate until ED11.5 follow-
ing deletion of HCN4 suggests that other mechanisms contribute
to cardiac pacemaking in these early stages. Why HCN4 is then
robustly expressed so early in the developing heart? A possi-
ble answer comes from the analysis of another transgenic HCN
model. Recently Harzheim et al. (2008) have developed a mouse
carrying a single amino acid substitution (R669Q) within the
CNBD of HCN4 which makes the subunit completely insensitive
to cAMP stimulation. Surprisingly, HCN4R669Q/R669Q homozy-
gous mice die at ED111–ED12 and before that time point they
show a reduced heart rate similar to that of both global and
cardiac-specific constitutive HCN4 KO mice. When HCN4 protein
expression and I f current were analyzed in HCN4
R669Q/R669Q mice,
they did not show any down-regulation and the only difference
was the expected lack of sensitivity to cAMP with a consequent
activation at more negative potentials. These data indicate that,
although HCN4 channels contribute to pacemaking as soon as
the tubular heart starts to contract, their contribution becomes
more important after ED9.5 when the SAN starts to develop from
mesenchymal precursors (Wiese et al., 2009). At ED12.5, when the
SAN is formed, HCN4R669Q/R669Q channels failure to respond to
adrenergic stimulation becomes incompatible with life as previ-
ously indicated (Portbury et al., 2003; Chandra et al., 2006). Other
evidence confirming the importance of HCN4 channels during
embryonic development derives from another KO mouse with a
constitutive deletion of Shox2, a transcription factor participating
in the specific development of the SAN (Christoffels et al., 2010).
The removal of shox2 does not cause any functional alterations in
the heart up to ED10.5 when a severe bradycardia (50% compared
to wild type animals) and a decrease of HCN4 expression become
evident. Shox2-deleted mice die between ED11.5 and ED12.5
(Espinoza-Lewis et al., 2009) as observed with HCN4 KO mice.
ROLE OF HCN4 CHANNELS IN ADULT MICE
Previous studies using constitutive global or cardiac-specific dele-
tion of HCN4 isoforms (Stieber et al., 2003) have revealed that the
presence of HCN4 is required for the correct functional develop-
ment of the embryonic heart; nonetheless the prenatal lethality
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Table 1 | Phenotypic manifestations of HCN KO/transgenic mouse models.
Models In vivo effects in embryos Isolated heart Isolated cardiomyocytes Reference
Constitutive global HCN4 KO Embryonic lethality (ED 9.5–11.5) Stieber et al. (2003)
Constitutive cardiac-specific
HCN4 KO
Embryonic lethality (ED 9.5–11.5) ↓ HR (−36.7%)
No response to cAMP
I f: ↓ (−75/−90%) Stieber et al. (2003)
No response to cAMP
APs: absence of mature
Pacemaker-like APs
No response to cAMP
Constitutive global
HCN4R669Q/R669Q transgenic
Embryonic lethality (ED 11–12) ↓ HR (−40/−60%)
No response to Iso
I f: slower activation and
shift of the AC (−13 mV)
Harzheim et al. (2008)
No response to cAMP
APs: ↓ rate (−36/−56%)
In vivo effects in adult Isolated SAN cells
Inducible global HCN4 KO Sinus arrhythmias(pauses)
Normal response to Iso
I f: ↓ (−75%) Herrmann et al. (2007)
Faster activation; no shift of the AC
Normal response to Iso
APs: no spontaneous activity in 90% of the cells;
when present, spontaneous rate is normal
Inducible HCN4-expressing
cells HCN4 KO (KiT-HCN4 KO)
Arrhythmia (sinus pauses) I f: ↓ (−80%) Hoesl et al. (2008)
Normal response to Iso Faster activation, no shift of the AC
↑ Response to Carb APs: no spontaneous activity in 45% of the cells;
when present, spontaneous rate is normal
Inducible cardiac-specific
HCN4 KO (Ci-HCN4 KO)
↓ Basal HR (−50%) I f: ↓ (−70%) Baruscotti et al. (2011)
No changes in kinetics, no shift of the AC
PQ prolongation Normal response to Iso
↓Maximal response to Iso APs: ↓ Rate (−61%)
AV block and death ↓Maximal response to Iso
Inducible cardiac-specific
HCN4–573X KI
↓ Basal HR (−20%) I f: no reduction Alig et al. (2009)
Slower activation; shift of the AC (−20 mV)
No response to Iso
↓ Exercise-induced HR APs: irregular pacemaker activity in 88% of the cells
↓ Rate (−33%)
↓Maximal response to Iso
Constitutive global HCN2 KO Absence epilepsy and sinus
dysrhythmia
I f: ↓ (−30%) Ludwig et al. (2003)
Slower activation; no shift of the AC
Normal response to cAMP
Constitutive cardiac-specific
HCN2 KO
Sinus dysrhythmia Ludwig et al. (2003)
Constitutive global HCN3 KO Regular sinus rhythm Isolated epicardial cells Fenske et al. (2011)
↑T-wave amplitude (+63.5%) and
duration (+15%) at low heart rates
I f: ↓ (−30%)
APs: shortening of the AP duration
↑ QT interval (+12%)
associated with this model has prevented further investigation
of the role of the I f current in adult cardiac pacemaking. This
aspect was therefore addressed by means of temporally controlled
induction of gene knockout methodology.
INDUCIBLE KO MODELS
The first inducible HCN4 KO model was developed in 2007 by
Herrmann et al. (2007) who engineered a transgenic mouse line by
inserting LoxP sites in the regions flanking the exon 4 of the Hcn4
gene (encoding the pore and the S6 transmembrane domain).
This line was then crossed with the CAGGCre-ERtm mouse
line (Hayashi and McMahon, 2002) to ensure the ubiquitous
expression of a tamoxifen-inducible Cre construct and thus a gen-
eralized removal of the HCN4 isoforms from the entire organism.
The following year the same group (Hoesl et al., 2008) produced
a new transgenic mouse line with an inducible Cre inserted in-
frame into the Hcn4 start codon; thus allowing the knockout event
to occur only in HCN4-expressing cells. The effective deletion of
HCN4 channels was confirmed in both models by PCR, west-
ern blot, and immunoistochemical detection experiments, and by
patch-clamp studies in single SAN cells isolated from KO mice;
the latter showed that the I f current decreased of about 75–80%.
Despite this large current reduction,ECG recordings in freely mov-
ing HCN4 KO mice did not reveal major alterations of the cardiac
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electrical activity. The only evidence of an arrhythmic behavior
was the presence of sinus pauses (8–16 pauses/min with an average
duration of 321 ms) between periods of normal activity character-
ized by mean basal rates which did not differ from that of control
mice. Interestingly, the number of pauses was inversely related to
the heart rate, and the highest number of pauses (up to 8.1/min)
occurred at heart rates of about 300–450 bpm; the presence of
sinus pauses was also confirmed in ECG recordings of isolated
hearts (Herrmann et al., 2007). Studies of spontaneous activity of
isolated single SAN cells did not produce similar results since the
authors report that a large fraction (45–90%) of the cells lack the
ability to fire spontaneously (Herrmann et al., 2007; Hoesl et al.,
2008) and in those cells in which repetitive APs were present, their
features did not differ from those observed in SAN cells from wild
type animals. This remarkable difference between the appearance
of sinus pauses in the intact animal/isolated heart and the lack of
normal spontaneous activity as observed in single cells remains an
issue for which a convincing explanation is still lacking.
The I f current has previously been shown to be an impor-
tant target of autonomic modulators and single cells studies have
shown that the β-adrenergic/muscarinic modulation of single cell
firing rate reflects the increased/reduced I f current flowing dur-
ing diastole (Bucchi et al., 2007; Mangoni and Nargeot, 2008).
For this reason these mouse models were also employed to verify
whether autonomic modulation of heart rate could be altered in
the absence of HCN4 channels. Maximal sympathetic activation
due to isoproterenol administration (0.5 mg/kg i.p.) or physi-
cal exercise (treadmill) in freely moving HCN4 knockout mice
elicited a rate response that was not different from that of control
mice (∼700 bpm), but upon return to basal rate the number of
pauses observed in KO mice was increased up to fourfold (Her-
rmann et al., 2007). Perhaps a more interesting finding came from
muscarinic stimulation since the heart rate reduction observed in
HCN4 KO mice was significantly larger than that elicited in control
mice, thus suggesting that the depolarizing contribution of HCN4
channels may be required to partially counteract the bradycardic
effect due to strong activation of the parasympathetic arm of the
sympathovagal balance (Herrmann et al., 2007; Hoesl et al., 2008).
Taken together, the results obtained with these inducible mod-
els suggest that ablation of HCN4 in the adult animal has lim-
ited effects on cardiac pacemaker generation and modulation.
These results appear therefore to challenge the previously accepted
idea that considered the I f current/HCN4 channels a major
determinant of SAN pacemaking.
However, a pitfall of the previous inducible models was the lack
of cardiac-specificity. Indeed, both the generalized removal of the
HCN4 isoform in the entire organism (Herrmann et al., 2007) and
the selective ablation only in HCN4-expressing cells (Hoesl et al.,
2008) imply that HCN4 knockout occurs not only in the heart, but
also in brain areas expressing the HCN4 channels. It is therefore
likely that neuronal- and cardiac-induced effects of the KO process
overlap thus confounding the interpretation of data. In order to
allow for a cardiac-specific HCN4 removal, our group developed
a mouse knockout model by crossing a novel floxed HCN4 mouse
line (Baruscotti et al., 2011) with a Cre mouse carrying the Cre-
recombinase under the control of the cardiac-specific α-myosin
heavy chain (αMHC) promoter (Sohal et al., 2001). This knockout
protocol ensures an inducible and cardiac-restricted ablation of
the HCN4 isoforms. In this model the loxP sites were inserted
in the region flanking the exon 2 which encodes for the region
comprising most of the S1 up to the entire S4 transmembrane seg-
ments. The recombination process led to a frame-shift generating
an early stop codon but it is not known whether the putative trun-
cated protein is made or not (Figure 1A). The knockout process
was induced by i.p. injection of tamoxifen for five consecutive
FIGURE 1 | (A)Top, left: structure of the floxed HCN4 gene carrying the
loxP sites (triangles) in the introns flanking exon 2 of the inducible
cardiac-specific HCN4 KO mouse model. Top, right: structure of the wild
type HCN4 protein isoform. Bottom, left: HCN4 gene structure after the
Cre-induced recombination; the gene is now lacking exon 2. Bottom, right:
Removal of exon 2 eliminates the first four transemembrane segments and
generates a frame-shift leading to an early stop-codon 3 residues
downstream to the recombination site. The hypothetical resulting protein
should therefore be formed by the N-terminus and by a small portion of the
S1 segment. No data on the presence/absence of both transcript and
protein are available (B) Bottom: Mean I f current densities measured during
hyperpolarization steps at the indicated potentials (holding potential
−35 mV) from SAN cells isolated from cardiac-specific HCN4 KO mice
before (dashed bars) and 5 days after (empty bars) KO induction (tamoxifen
treatment). Top: Representative I f traces recorded at the same potentials.
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days. This model yielded completely different results than previous
non-cardiac-specific models.
The KO induction in freely moving mice resulted in the devel-
opment of a progressive slowing of the heart rate, without the
appearance of anomalous sinus pauses. Five days after the initia-
tion of the tamoxifen treatment, the average heart rate observed
by telemetric ECG recordings was reduced by about 50% rela-
tive to control (Figure 2). In this model, therefore, removal of
HCN4 channels was clearly associated with the appearance of
severe bradycardia. The effective ablation of HCN4 proteins was
confirmed by immunolabeling of SAN tissue and single cells and
by western blot experiments; patch-clamp recordings quantified
the KO effect in a 70% reduction of the I f current (Figure 1B).
The cellular origin of the bradycardia was then further investigated
FIGURE 2 | (A)Top: Representative telemetric ECG traces recorded from
freely moving mice before (left) and after (right) cardiac-specific HCN4
ablation (five tamoxifen injections). Bottom: Sample action potentials
recorded from SAN cells isolated before (left) and after (right) the knockout.
(B) Bar-graph showing normalized telemetric heart rates of control (left) and
KO (middle left) mice recorded before (day 0) and during the Tam-procedure
(day 2 and day 5). The normalized spontaneous activity (middle right) and
the I f current conductance (right) of SAN cells isolated from KO mice in the
same days. Clearly the induction of the knockout decreases the heart rates
of freely moving animals, the spontaneous activity of isolated SAN cells,
and the I f current conductance (gf) in a similar manner. Only a minor heart
rate reduction was observed in control animals undergoing the same
treatment.
by comparing the spontaneous activity of single SAN cells isolated
from control and KO animals. KO induction reduced but did not
abolish the spontaneous firing of SAN cells (by about 61% at day
5) and the time-course of this effect nicely overlapped the brady-
cardic onset in intact animals (Figure 2B). Clearly, the similar time
courses of heart rate bradycardia and slowing of spontaneous fir-
ing of single cells, proceeding in parallel with the reduction of the
I f current, indicate a strict correlation between I f current and rate.
This knockout model also allowed the evaluation of the rel-
evance of the I f current to the modulation of the cardiac rate
induced by β-adrenergic activation. Isoproterenol stimulation
(Iso,0.1 mg/kg, i.p.) increased rate in both control and KO mice but
maximal rate values were significantly different (705 vs. 485 bpm,
respectively). In agreement with the results in intact animals, the
average maximal rate of spontaneously beating single cells per-
fused with Iso (1µM) was significantly higher in control cells
(489 bpm) than in KO SAN cells (280 bpm). Despite these differ-
ences in maximal rates, the Iso-induced accelerations were similar
in telemetric recordings from control and KO animals (193 vs.
185 bpm, respectively) and in single control and HCN4 KO SAN
cells (120 vs. 143 bpm,respectively). The evidence that knockout of
HCN4 channels reduces both basal rate and maximal β-adrenergic
response in intact animals and in single cells provides a direct
demonstration that the I f current plays a prominent role in basal
rhythm generation and modulation.
Bradycardia and chronotropic incompetence were not the only
effects observed in the cardiac-specific HCN4 knockout model.
HCN4 knockout also leads to a prolongation of the PQ interval
(from 32.7 ms before induction to 45.6 ms after full tamoxifen
treatment) and AV block, eventually leading to heart arrest and
death of the animal. During AV block, sinus rhythm was always
present albeit with a reduced rate. The unexpected observation
that HCN4 KO impairs more dramatically the AVN than the SAN
function (i.e., the AVN is more sensitive than the SAN to f-channel
removal) remains a significant and intriguing result that awaits
further confirmation and interpretation.
COMPARISON AMONG ADULT INDUCIBLE HCN4 KNOCKOUT MODELS
Ideally all adult HCN4 KO models investigated should have yielded
similar or at least coherent results, which however were not
observed. Herrmann and Hoesl’s models (Herrmann et al., 2007;
Hoesl et al., 2008) led to the conclusion that the I f current does
not substantially contribute to basal heart rate or rate accelera-
tion induced by sympathetic stimulation. On the contrary, our
cardiac-specific model revealed strong effects since a 50% reduc-
tion in rate was observed in KO mice, all mice died due to complete
AV block, and chronotropic response to maximal β stimulation
was about 30% smaller than in control mice. We do not have a
simple explanation for the observation that complete and HCN4-
expressing restricted knockout do not lead to the deep bradycardia
observed with cardiac-specific knockout. However, in addition
to the intrinsic difference in the models, two additional aspects
should be considered. A first difference between our KO mice and
Herrmann and Hoesl’s (Herrmann et al., 2007; Hoesl et al., 2008)
is that while in Herrmann and Hoesl’s models the knockout pro-
cedure ablates exon 4, and does not produce a frame-shift of the
remaining sequence, our model ablates exon 2 and generates a
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stop codon three residues downstream the site of recombination
(Baruscotti et al., 2011). Whether this difference may or may not
produce any different results is not clear, since apparently both
procedures generate non-functional channels. The second aspect
relates to the genetic background of the mice. Although all the dis-
cussed mouse models have the same C57BL6 genetic background,
this does not necessarily mean that they are genetically similar
since recent evidence indicates the existence of multiple C57BL6
sub-strains (Kiselycznyk and Holmes, 2011), and significant phe-
notypic differences among sub-strains have been reported (Blum
et al., 1982; Bryant et al., 2008; Matsuo et al., 2010). We there-
fore cannot fully rule out that some functional differences among
HCN4 KO and transgenic models may arise from the combination
of methodological and genetic factors.
Among different models, when single SAN cell data collected in
control conditions are considered, a large variability in cell capac-
itance, spontaneous rate, and kinetics features of the I f current is
observed among different models (Herrmann et al., 2007; Hoesl
et al., 2008; Baruscotti et al., 2011). This variability is not a spe-
cific feature of knockout model studies, since it is largely present
throughout the whole SAN cell literature (Boyett et al., 2000; Bar-
uscotti et al., 2005; Mangoni and Nargeot, 2008). Whether this
difference arises from a biased selection of specific cells is difficult
to establish.
Upon physical exercise, or under isoprenaline stimulation, all
HCN4 KO models display heart/cell rate accelerations which are
not different from those elicited in control mice. Despite the sim-
ilar acceleration, the maximal rate attained by the cardiac-specific
KO mice model is substantially lower than that elicited in control
and in complete or HCN4-restricted mice (Herrmann et al., 2007;
Hoesl et al., 2008; Baruscotti et al., 2011); this is at least in part
due to the fact that cardiac-specific KO mice have a lower basal
rate. While taken at face value the permanence of modulation in
cardiac-specific KO mice apparently suggests that HCN4 channels
are not responsible for this modulation, this conclusion is con-
tradicted by the evidence that the remaining I f current in cardiac
HCN4 KO mice is still amply modulated, and therefore can still
contribute to iso-induce acceleration.
Although the experimental data amongst models are substan-
tially different, we believe that an organ-specific gene ablation is
the correct technique to investigate functional roles of mechanisms
restricted to the organ itself. We also think that the ultimate pur-
pose of a KO mouse model is to improve the understanding of the
physiological aspects and pathological consequences in humans;
our model is adequate to the purpose, since results obtained with
the mouse KO model correspond to results obtained in humans,
where it is known that a reduction of the I f current either resulting
from genetic mutations (Baruscotti et al., 2010b) or pharmaco-
logical blockade (DiFrancesco and Camm, 2004) leads to sinus
bradycardia.
INDUCIBLE TRANSGENIC MODELS
The role of HCN4 channels in the adult heart has been evalu-
ated also by Alig et al. (2009) who developed a transgenic mouse
model with an α-MHC promoter and a Tet-Off system-controlled
cardiac-specific expression of an engineered human HCN4 sub-
unit carrying a mutation previously identified in a patient with
SAN dysfunction (hHCN4–573X; Schulze-Bahr et al., 2003). The
patient had marked sinus bradycardia (41 bpm) and intermittent
episodes of atrial fibrillation; a diagnosis of idiopathic sinus node
dysfunction was made and a pacemaker was implanted. In vitro
experiments based on patch-clamp-studies of the heterologously
expressed mutant channels showed that the mutation abolished
the cAMP-dependent regulation of HCN4 channels in a dominant
negative manner (Schulze-Bahr et al., 2003). This model therefore
did not induce an HCN4 knockout, but rather conferred to cardiac,
and in particular to SAN cells, the presence of a mutated human
HCN4 subunit which is fully insensitive to cAMP modulation.
Analysis of the ECG of conscious animals overexpressing the
mutant hHCN4–573X channels revealed that the heart rate at rest
was some 20% slower than that of control mice and no changes in
PQ and QTc intervals were observed. In transgenic mice physical
exercise was still able to elicit a positive modulation of heart rate,
although to a significantly lesser degree than that observed in con-
trol mice exposed to a similar activity. The I f current recorded in
transgenic SAN cells exhibited slower activation kinetics and a neg-
ative shift of about 20 mV of its voltage-dependence. Spontaneous
oscillations of these cells were also severely impaired since most of
the cells were either quiescent (∼28%) or showed an arrhythmic
behavior (∼61%) consisting in periods of sub-threshold mem-
brane potential oscillations followed by regular firing though at a
reduced rate. Regular firing was observed only in 11% of the cells
investigated. Iso application resulted in pacing acceleration and
restoration of regular pacemaker activity in arrhythmic mutant
cells, although maximal rates were significantly slower than in
controls cells.
This model (Alig et al., 2009) is substantially different from pre-
vious inducible models and therefore trying to compare the results
would be partially inappropriate. Nevertheless, in these mice the
functionality of sinoatrial I f current was severely impaired due to a
negative shift of its voltage-dependence and a lack of cAMP mod-
ulation; thus, the conclusion that a reduced contribution of the I f
current leads in mice to bradycardia and chronotropic incompence
is compatible with the results from our KO model (see above).
On the other hand, the observation that most of single isolated
SAN cells were quiescent points to a similarity with the results of
Herrmann et al. (2007) and Hoesl et al. (2008).
The transgenic hHCN4–573X mouse model was also used by
Marger et al. (2011) to investigate the role of HCN4 channels in
AVN cells. This study showed that while basal spontaneous rate of
transgenic AVN cells was reduced when compared to control cells,
the maximal rates attained under Iso stimulation was not different
between the two groups. While cells isolated from the SAN and the
AVN of hHCN4–573X mice display similarly reduced basal rates,
their response to maximal stimulation is clearly different although
the underlying mechanism are not clear.
MOUSE MODELS OF INDUCIBLE KNOCKOUT OF SAN CELLS
Recently Herrmann et al. (2011a) developed a mouse model
where it is possible to eliminate in an inducible manner HCN4-
expressing cardiomyocytes. The model was obtained by crossing a
mouse line with the Cre inserted into the ATG codon of the Hcn4
gene (Herrmann et al., 2007; Hoesl et al., 2008) with a ROSA-eGFP-
DTA line able to express Diphtheria Toxin (DT) upon Cre-induced
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removal of a floxed stop sequence. Tamoxifen-induced activity of
DT leads to a dose-dependent elimination of SAN cells and to
their substitution with collagen fibers. Despite the large differences
between this model and the inducible and cardiac-specific HCN4
KO model developed by our group (Baruscotti et al., 2011), the
similarities of the phenotypic manifestations are many. In freely
moving conscious mice the induction of DT (five consecutive days
of tamoxifen injection) caused a substantial bradycardia (−40%:
from 493 to 275 bpm) comparable with that reported in our
model (50% reduction). Isoprenaline administration (0.5 mg/kg
i.p.) increased heart rate in both control (by 199 bpm) and DT-
expressing mice (by 69 bpm) and the maximal value attained by
DT-expressing mice was 447 bpm, a value which is similar to that
reported in our experiments (∼486 bpm, Iso 0.1 mg/kg i.p.).
Together with bradycardia, the DT-expressing mice also showed
additional arrhythmic features such as: increased PR interval, com-
plete heart block, sino-atrial pauses and supraventricular or ven-
tricular tachycardia. Whether this model is adequate to describe
the primary features of the age-related sick sinus syndrome is still a
matter of debate (Morris et al., 2011). As noted above the destruc-
tion of HCN4-expressing cells also impacts onto the AV node
conduction of the impulse as verified by the increase of the PR
interval, and remarkably this effect was observed in the model of
Baruscotti et al. but no in other models (Herrmann et al., 2007;
Hoesl et al., 2008; Alig et al., 2009).
ROLE HCN2 AND HCN1 IN ADULT MICE
The presence of the HCN2 isoform in the mouse adult heart
is mostly confined to the ventricle, while in the atria and in
the SAN HCN2 expression is hardly detectable. Despite the lim-
ited expression, experiments with both global and cardiac-specific
constitutive HCN2-deficient mouse models (Ludwig et al., 2003)
have revealed a sinus dysrhythmic pattern. In addition, global
HCN2 KO mice were also affected by absence seizures. It is inter-
esting to note that these data are in agreement with results in
humans from our laboratory showing that a loss-of-function point
mutation in the HCN2 C-linker is associated with a form of gen-
eralized epilepsy with recessive inheritance (DiFrancesco et al.,
2011).
ECG analysis revealed that despite control and HCN2 KO mice
had similar cardiac rates at rest (531 vs. 510 bpm), the HCN2-
deficient animals displayed a much increased RR variability at
rest and during normal activity probably due to a dysfunction of
the SAN. RR variability measured as the Standard Deviation of RR
(SDRR) interval was 7.1 ms in control and in the range 14–17.1 ms
in mice lacking HCN2 subunits. Upon maximal stimulation (Iso
or physical activity) HCN2 KO mice were able to reach maxi-
mal rates similar to those of control mice (>670 bpm) and the
observed sinus dysrhythmia disappeared (SDRR in the range 3–
5 ms for both groups). Experiment in isolated SAN cells revealed
a decrease of about 30% of the I f current density, significantly
slower activation kinetics of the current, and a shift of about 5 mV
of the maximum diastolic potential to hyperpolarized values in
global KO mice myocytes. Since the remaining (non-HCN2) I f
current in KO cells was still modulated by cAMP, these data indi-
cate the HCN2 isoform contributes to cardiac pacemaking activity
of SAN cells mainly at rest and under non-stimulated conditions.
A generalize knockout HCN1 mouse model was developed by
(Nolan et al., 2003), and the authors report significant deficits in
neuronal process related to spatial memory and learning ability.
Since no embryo lethality or anatomical and functional alterations
of the adult heart are reported it can be assumed that knockout of
HCN1 subunits does not have a major impact on the heart. This
evidence is in agreement with a limited presence of HCN1 proteins
in the heart reported by some authors (Liu et al., 2007; Brioschi
et al., 2009); however it must be noted that in some other reports
HCN1 signal has been strongly detected in the SAN (Herrmann
et al., 2011b).
ROLE OF HCN3 IN ADULT/EMBRYONIC MICE
The HCN3 isoform has been investigated less deeply than other
isoforms in the cardiac field mostly because this isoform was ini-
tially thought to be expressed in neuronal and other types of tissue,
but less so in cardiac tissue. Currently very few studies of the elec-
trical properties of homomeric HCN3 channels have been carried
out (Chaplan et al., 2003; Mistrik et al., 2005; Stieber et al., 2005).
The presence of HCN3 mRNA and protein in SAN cells has been
investigated so far only in rodents and there is no indication of
a positive signal (Moosmang et al., 2001; Huang et al., 2007; Liu
et al., 2007; Fenske et al., 2011; Herrmann et al., 2011b). There
is on the other hand contrasting evidence concerning the expres-
sion of HCN3 in the working myocardium. Some groups failed to
detect positive signals by in situ hybridization and real time PCR
in mice and rat hearts (Moosmang et al., 2001; Huang et al., 2007;
Herrmann et al., 2011b), while other found a weak RT-PCR posi-
tive signal in mouse heart and ventricles (Marionneau et al., 2005;
Mistrik et al., 2005). Despite the positive mRNA identification
Mistrik et al. (2005) failed to confirm the presence of HCN3 pro-
teins likely because the signal was below the detection level. On the
other hand, Fenske et al. (2011) reported positive mRNA identifi-
cation in working myocardium and positive protein identification
in mouse ventricles and generated a global and constitutive HCN3
knockout mouse by ablating the exon 2 of the Hcn3 gene. Since
HCN3-deficient mice were born at the expected Mendelian ratios
with normal mice, it can be concluded that this isoform is not rel-
evant for cardiac formation and development. In agreement with
the lack of HCN3 mRNA and protein in the SAN, ECGs recorded
from freely moving HCN3-deficient mice did not reveal anomalies
in sinus rhythm. Important evidence supporting a contribution of
the HCN3 isoform to the physiology of the working myocardium
comes from the finding that at low heart rates (mean of 460 bpm)
significant increases in the T-wave amplitude (+63.5%) and dura-
tion (+15%) and in the QT interval (+12%) were detected.
Patch-clamp analysis of epicardial cells from HCN3 KO mice
showed a substantial shortening of the action potential duration
(both APD75 and APD90) and a ∼30% reduction of the I f cur-
rent. Analysis of the steady-state voltage-dependence of the HCN3
channels revealed that at the cell resting voltage (−85 mV) about
25–30% of the channels are in the conducting state. This piece of
information, and the extremely slow kinetic of deactivation allow
to formulate the hypothesis that the HCN3 component of the ven-
tricular epicardial I f current is active throughout the entire action
potential and exerts its functional action by counteracting the K+
current-driven late repolarization of epicardial cells.
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While these data certainly highlight a novel contribution of
pacemaker channel to cardiac function we believe that there are
some points that need to be addressed: (1) the contrasting reports
in the literature regarding the presence of the HCN3 isoform in
the heart pose the question as whether the results of this model
can be generalized; (2) as pointed out by the same authors it is still
to be determined why the phenotypic manifestations can only be
observed in epicardial cells given that endocardial cells also express
HCN3 proteins; (3) last but not the least is to verify whether HCN3
isoforms are also present in human epicardial cardiomyocytes.
CONCLUSIONS
HCN channels represent an important source of depolarizing cur-
rent in the heart, and the use of specific constitutive or temporally
controlled deletion of different HCN isoforms has allowed to bet-
ter understand the contribution of each isoform to the different
functional aspects of cardiac myocytes.
Despite some variability, in the literature there is a general
agreement that the HCN2 isoform is mostly confined to the ventri-
cle; while in other cardiac district and especially in the SAN HCN2
channels are poorly expressed. The very limited contribution of
HCN2 subunits to cardiac pacemaking is confirmed by the finding
that the heart rates of HCN2 KO mice at rest and under maximal
chronotropic modulation do not differ from those of control ani-
mals. Furthermore HCN2 are not functionally essential to heart
formation during embryogenesis and maturation.
HCN3 subunits have long been regarded as little relevant to
cardiac activity. Lately however ECG recordings in global and con-
stitutive HCN3 KO mice have been reported to display alterations
of the T-wave and of the QT interval. Interpretation of these data
has led to the hypothesis that HCN3 channels represent a source of
ventricular background current which opposes to the repolarizing
process at the end of the ventricular APs.
HCN4 is by far the most important isoform in the heart, and
its presence is most abundant in the SAN where HCN4 repre-
sents about 80% of the total HCN isoforms. Several HCN4 KO
and transgenic mouse models have been developed and results
are extremely variable (Table 1). Results with the cardiac-specific
and inducible knockout model indicate that the HCN4 current
provides a fundamental contribution to basal heart rate mainte-
nance and modulation since its removal leads to basal bradycardia
and a strongly reduced response to sympathetic stimulation. Fur-
thermore the HCN4 current plays a critical role also in AV node
conduction.
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